BrightPath Biotherapeutics Co., Ltd.JP:4594
Market cap
¥4.5B
P/E ratio
-3.7x
| 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Depreciation & amortization | 9 | 19 | 42 | 73 | 83 | 62 | 67 | 35 | 17 | 0 | - |
| Cash from operations | -447 | -909 | -1,068 | -1,591 | -1,458 | -1,784 | -1,770 | -1,512 | -1,204 | -1,157 | -1,250 |
| Capital expenditures | -41 | -23 | -97 | -108 | -173 | -107 | -35 | -18 | -1 | -6 | -1 |
| Cash from investing | -67 | -32 | -97 | -112 | -185 | -107 | -36 | -18 | -2 | -8 | -1 |
| Repurchases of common stock | - | - | - | - | - | - | - | - | - | - | -0 |
| Cash from financing | 1,248 | 2,673 | 3,559 | 3,281 | 16 | 9 | 2,053 | 569 | 432 | 691 | 1,005 |